Terms: = Lymphoma AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV
19 results:
1. Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Georgi TW; Kurch L; Franke GN; Jentzsch M; Schwind S; Perez-Fernandez C; Petermann N; Merz M; Metzeler K; Borte G; Hoffmann S; Herling M; Denecke T; Kluge R; Sabri O; Platzbecker U; Vučinić V
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6131-6138. PubMed ID: 36662305
[TBL] [Abstract] [Full Text] [Related]
2. Pulmonary Outcomes After Autologous Stem Cell Transplant for Hodgkin lymphoma.
Davidow K; Bunin N; Goldfarb S; Li Y; Freedman JL
J Pediatr Hematol Oncol; 2022 Aug; 44(6):e926-e929. PubMed ID: 34486541
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.
Archangelidi O; Cullinan P; Simmonds NJ; Mentzakis E; Peckham D; Bilton D; Carr SB
J Cyst Fibros; 2022 Mar; 21(2):302-308. PubMed ID: 34348871
[TBL] [Abstract] [Full Text] [Related]
4. Sarcopenia and low muscle radiodensity associate with impaired fev
Mishra A; Bigam KD; Extermann M; Faramand R; Thomas K; Pidala JA; Baracos VE
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1570-1579. PubMed ID: 32729255
[TBL] [Abstract] [Full Text] [Related]
5. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
[TBL] [Abstract] [Full Text] [Related]
6. Expression of the fetal hematopoiesis regulator fev indicates leukemias of prenatal origin.
Liu TH; Tang YJ; Huang Y; Wang L; Guo XL; Mi JQ; Liu LG; Zhu H; Zhang Y; Chen L; Liu X; Zhang LH; Ye QJ; Li BS; Tang JY; Ford A; Enver T; Liu F; Chen GQ; Hong DL
Leukemia; 2017 May; 31(5):1079-1086. PubMed ID: 27807368
[TBL] [Abstract] [Full Text] [Related]
7. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
[TBL] [Abstract] [Full Text] [Related]
8. (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
Mylam KJ; Kostakoglu L; Hutchings M; Coleman M; Lamonica D; Czuczman MS; Diehl LF; Nielsen AL; Jensen P; Loft A; Hendel HW; Iyer V; Leppä S; Jyrkkiö S; Holte H; Eriksson M; Gillstrøm D; Hansen PB; Seppänen M; Hjorthaug K; Brown Pde N; Pedersen LM
Leuk Lymphoma; 2015 Jul; 56(7):2005-12. PubMed ID: 25330442
[TBL] [Abstract] [Full Text] [Related]
9. Pulmonary complications in survivors of childhood hematological malignancies: single-center experience.
Tantawy AA; Elbarbary N; Ahmed A; Mohamed NA; Ezz-Elarab S
Pediatr Hematol Oncol; 2011 Aug; 28(5):403-17. PubMed ID: 21728717
[TBL] [Abstract] [Full Text] [Related]
10. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Furth C; Steffen IG; Amthauer H; Ruf J; Misch D; Schönberger S; Kobe C; Denecke T; Stöver B; Hautzel H; Henze G; Hundsdoerfer P
J Clin Oncol; 2009 Sep; 27(26):4385-91. PubMed ID: 19667276
[TBL] [Abstract] [Full Text] [Related]
11. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
[TBL] [Abstract] [Full Text] [Related]
12. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
[TBL] [Abstract] [Full Text] [Related]
13. Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies.
Fanning SR; Rybicki L; Kalaycio M; Andresen S; Kuczkowski E; Pohlman B; Sobecks R; Sweetenham J; Bolwell B
Br J Haematol; 2006 Nov; 135(3):374-81. PubMed ID: 16995885
[TBL] [Abstract] [Full Text] [Related]
14. Functional status and quality of life in patients surviving 10 years after lung transplantation.
Rutherford RM; Fisher AJ; Hilton C; Forty J; Hasan A; Gould FK; Dark JH; Corris PA
Am J Transplant; 2005 May; 5(5):1099-104. PubMed ID: 15816892
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
Gopal R; Ha CS; Tucker SL; Khouri IF; Giralt SA; Gajewski JL; Andersson BS; Cox JD; Champlin RE
Cancer; 2001 Oct; 92(7):1949-58. PubMed ID: 11745270
[TBL] [Abstract] [Full Text] [Related]
16. Pet ownership and childhood acute leukemia (USA and Canada).
Swensen AR; Ross JA; Shu XO; Reaman GH; Steinbuch M; Robison LL
Cancer Causes Control; 2001 May; 12(4):301-3. PubMed ID: 11456225
[TBL] [Abstract] [Full Text] [Related]
17. 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.
de Wit M; Bohuslavizki KH; Buchert R; Bumann D; Clausen M; Hossfeld DK
Ann Oncol; 2001 Jan; 12(1):29-37. PubMed ID: 11249046
[TBL] [Abstract] [Full Text] [Related]
18. Changes in airway responsiveness following mantle radiotherapy for Hodgkin's disease.
Rolla G; Ricardi U; Colagrande P; Nassisi D; Dutto L; Chiavassa G; Bucca C
Chest; 2000 Jun; 117(6):1590-6. PubMed ID: 10858388
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical characterization of microvascular endothelial cells in primary B cell lymphoma of the gastrointestinal tract.
Saito Y; Morise K; Nagura H
Am J Gastroenterol; 1991 Mar; 86(3):297-303. PubMed ID: 1998311
[TBL] [Abstract] [Full Text] [Related]
